Abstract
Recently, Roig et al reported a significant improvement in five children with nonhereditary chorea of various origins by treating them with carbamazepine, 15 to 25 mg/kg. However, as discussed by these authors, the fluctuating and self-limited course of these disorders makes the efficacy of any drug difficult to demonstrate.
Benign dominant hereditary chorea of early onset has a chronic course and, most adult patients, even welladjusted ones, have persistent motor impairment.
- Copyright © 1989 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.